Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis. Checa A, Khademi M, Sar DG, Haeggström JZ, Lundberg JO, Piehl F, Olsson T, Wheelock CE Mult Scler. 2014 Dec 5. PMID: 25480867. Abstract CommentRecommendBookmarkWatch